EP3636248B8 - Topical compositions containing cross-linked glycosaminoglycans - Google Patents

Topical compositions containing cross-linked glycosaminoglycans Download PDF

Info

Publication number: EP3636248B8
Authority: EP; European Patent Office
Prior art keywords: compositions containing; topical compositions; containing cross; linked glycosaminoglycans; glycosaminoglycans
Prior art date: 2016-04-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

EP19210949.4A

Other languages

German (de)

French (fr)

Other versions

EP3636248A1 (en

EP3636248B1 (en

EP3636248C0 (en

Inventor

Ali Fassih

Jyotsna PATURI

Janet WANGARI-TALBOT

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kenvue Brands LLC

Original Assignee

Kenvue Brands LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-04-08

Filing date

2017-04-07

Publication date

2025-01-15

2017-04-07 Application filed by Kenvue Brands LLC, Kenvue Brands LLC filed Critical Kenvue Brands LLC

2020-04-15 Publication of EP3636248A1 publication Critical patent/EP3636248A1/en

2024-12-11 Application granted granted Critical

2024-12-11 Publication of EP3636248B1 publication Critical patent/EP3636248B1/en

2024-12-11 Publication of EP3636248C0 publication Critical patent/EP3636248C0/en

2025-01-15 Publication of EP3636248B8 publication Critical patent/EP3636248B8/en

Status Active legal-status Critical Current

2037-04-07 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Birds (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Gerontology & Geriatric Medicine (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP19210949.4A 2016-04-08 2017-04-07 Topical compositions containing cross-linked glycosaminoglycans Active EP3636248B8 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201662319847P	2016-04-08	2016-04-08
EP17165566.5A EP3228305B1 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans

Related Parent Applications (2)

Application Number	Title	Priority Date	Filing Date
EP17165566.5A Division EP3228305B1 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans
EP17165566.5A Division-Into EP3228305B1 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans

Publications (4)

Publication Number	Publication Date
EP3636248A1 EP3636248A1 (en)	2020-04-15
EP3636248B1 EP3636248B1 (en)	2024-12-11
EP3636248C0 EP3636248C0 (en)	2024-12-11
EP3636248B8 true EP3636248B8 (en)	2025-01-15

Family

ID=58501380

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP19210949.4A Active EP3636248B8 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans
EP17165566.5A Active EP3228305B1 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP17165566.5A Active EP3228305B1 (en)	2016-04-08	2017-04-07	Topical compositions containing cross-linked glycosaminoglycans

Country Status (9)

Country	Link
EP (2)	EP3636248B8 (en)
JP (2)	JP7039178B2 (en)
KR (1)	KR102451205B1 (en)
CN (1)	CN107260574B (en)
AU (1)	AU2017202316B2 (en)
CA (1)	CA2961868A1 (en)
ES (1)	ES2775726T3 (en)
MX (1)	MX369163B (en)
RU (1)	RU2748750C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2961868A1 (en) *	2016-04-08	2017-10-08	Johnson & Johnson Consumer Inc.	Topical compositions containing cross-linked glycosaminoglycans
US10959933B1 (en)	2020-06-01	2021-03-30	The Procter & Gamble Company	Low pH skin care composition and methods of using the same
US11583488B2 (en)	2020-06-01	2023-02-21	The Procter & Gamble Company	Method of improving penetration of a vitamin B3 compound into skin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0611694B2 (en) *	1985-01-29	1994-02-16	生化学工業株式会社	Skin cosmetics
US4863907A (en) *	1984-06-29	1989-09-05	Seikagaku Kogyo Co., Ltd.	Crosslinked glycosaminoglycans and their use
GR920100122A (en) *	1991-04-05	1993-03-16	Ethicon Inc	Ionically crosslinked carboxyl-containing polysaccharides for adhension prevention.
FR2686249A1 (en) *	1992-01-16	1993-07-23	Olivier Josette	PREPARATION FOR CUTANEOUS USE BASED ON LIPOSOMES.
US5945409A (en) *	1995-03-10	1999-08-31	Wilson T. Crandall	Topical moisturizing composition and method
FR2865737B1 (en) *	2004-02-03	2006-03-31	Anteis Sa	BIOCOMPATIBLE RETICLE GEL
US20050226936A1 (en) *	2004-04-08	2005-10-13	Q-Med Ab	Method of soft tissue augmentation
JP4035553B2 (en) *	2006-03-20	2008-01-23	株式会社日本バリアフリー	Method for producing useful composition
FR2909560B1 (en) *	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	HYALURONIC ACID GEL FOR INTRADERMAL INJECTION
US8394784B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
WO2010049562A1 (en) *	2008-10-28	2010-05-06	Universidade De Santiago De Compostela	Nanoparticulate systems prepared from anionic polymers
CN102764198A (en) *	2011-05-06	2012-11-07	强生消费者公司	Composition containing hydrogel particles
WO2014014139A1 (en) *	2012-07-18	2014-01-23	Shin Hyunwoo	Two-component type composition for cosmetic pack and patch
WO2014142938A1 (en) *	2013-03-15	2014-09-18	Aihol Corporation	Pharmaceutical formulation containing glycosaminoglycan
CA2961868A1 (en)	2016-04-08	2017-10-08	Johnson & Johnson Consumer Inc.	Topical compositions containing cross-linked glycosaminoglycans

2017
- 2017-03-23 CA CA2961868A patent/CA2961868A1/en active Pending
- 2017-04-05 KR KR1020170044056A patent/KR102451205B1/en active Active
- 2017-04-06 RU RU2017111627A patent/RU2748750C2/en active
- 2017-04-07 EP EP19210949.4A patent/EP3636248B8/en active Active
- 2017-04-07 EP EP17165566.5A patent/EP3228305B1/en active Active
- 2017-04-07 MX MX2017004650A patent/MX369163B/en active IP Right Grant
- 2017-04-07 JP JP2017076569A patent/JP7039178B2/en active Active
- 2017-04-07 ES ES17165566T patent/ES2775726T3/en active Active
- 2017-04-07 AU AU2017202316A patent/AU2017202316B2/en active Active
- 2017-04-10 CN CN201710228887.3A patent/CN107260574B/en active Active
2021
- 2021-12-09 JP JP2021199929A patent/JP7366985B2/en active Active

Also Published As

Publication number	Publication date
MX2017004650A (en)	2018-08-16
ES2775726T3 (en)	2020-07-28
AU2017202316A1 (en)	2017-10-26
BR102017007126A8 (en)	2022-07-26
RU2017111627A3 (en)	2020-07-14
EP3228305A1 (en)	2017-10-11
JP7366985B2 (en)	2023-10-23
BR102017007126A2 (en)	2017-10-17
RU2748750C2 (en)	2021-05-31
JP2022022389A (en)	2022-02-03
AU2017202316B2 (en)	2022-06-30
CN107260574A (en)	2017-10-20
CA2961868A1 (en)	2017-10-08
JP7039178B2 (en)	2022-03-22
CN107260574B (en)	2022-04-12
EP3228305B1 (en)	2020-01-01
JP2017197520A (en)	2017-11-02
RU2017111627A (en)	2018-10-09
EP3636248A1 (en)	2020-04-15
KR102451205B1 (en)	2022-10-06
EP3636248B1 (en)	2024-12-11
KR20170115956A (en)	2017-10-18
EP3636248C0 (en)	2024-12-11
MX369163B (en)	2019-10-30

Publication	Publication Date	Title
EP3697376B8 (en)	2022-03-09	Composition
EP3240555A4 (en)	2018-12-05	Multi-supplement compositions
EP3339331A4 (en)	2019-05-01	Composition
EP3197432A4 (en)	2018-10-10	Topical corticosteroid compositions
AU2016291708B2 (en)	2020-12-24	Plinabulin compositions
EP3164196A4 (en)	2017-12-06	Topical formulations for uv protection
EP3584364A4 (en)	2020-01-15	Composition
EP3250196A4 (en)	2018-09-26	Healing topical composition
EP3248475A4 (en)	2018-08-01	Composition
EP3659581A4 (en)	2020-12-16	Topical composition
EP3439632B8 (en)	2024-05-22	Topical composition comprising tacrolimus
EP3288386A4 (en)	2018-10-03	Anti-phytopathogenic compositions
EP3264917A4 (en)	2018-08-15	Rebaudioside-d containing sweetener compositions
EP3480228A4 (en)	2020-03-11	Composition
EP3502226A4 (en)	2020-06-17	Gel composition
IL272944A (en)	2020-04-30	Topical compositions
EP3383912A4 (en)	2019-11-06	Topical formulations
EP3344265A4 (en)	2019-07-17	Topical antiviral compositions
EP3636248B8 (en)	2025-01-15	Topical compositions containing cross-linked glycosaminoglycans
EP3366730A4 (en)	2019-04-10	Water-based-ink composition
EP3331566A4 (en)	2019-04-10	Topical analgesis loton
EP3323837A4 (en)	2018-07-04	Composition
EP3804734A4 (en)	2022-03-09	Topical composition
IL268374A (en)	2019-09-26	Topical composition
EP3106160B8 (en)	2019-12-11	Combination composition comprising huperzine

Legal Events

Date	Code	Title	Description
2020-03-13	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-03-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED
2020-04-15	AC	Divisional application: reference to earlier application	Ref document number: 3228305 Country of ref document: EP Kind code of ref document: P
2020-04-15	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-10-16	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-11-18	17P	Request for examination filed	Effective date: 20201013
2020-11-18	RBV	Designated contracting states (corrected)	Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-04-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2021-05-05	17Q	First examination report despatched	Effective date: 20210407
2022-05-18	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: JOHNSON & JOHNSON CONSUMER INC.
2023-05-17	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: JOHNSON & JOHNSON CONSUMER INC.
2024-07-09	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2024-07-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2024-08-07	INTG	Intention to grant announced	Effective date: 20240710
2024-11-06	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2024-11-08	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2024-11-08	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2024-12-02	REG	Reference to a national code	Ref country code: DE Ref legal event code: R081 Ref document number: 602017086775 Country of ref document: DE Owner name: KENVUE BRANDS LLC, SUMMIT, US Free format text: FORMER OWNER: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, NJ, US
2024-12-11	AC	Divisional application: reference to earlier application	Ref document number: 3228305 Country of ref document: EP Kind code of ref document: P
2024-12-11	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2024-12-11	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2024-12-13	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2024-12-18	RAP4	Party data changed (patent owner data changed or rights of a patent transferred)	Owner name: KENVUE BRANDS LLC
2024-12-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PK Free format text: BERICHTIGUNG B8
2025-01-01	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2025-01-02	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602017086775 Country of ref document: DE
2025-02-19	U01	Request for unitary effect filed	Effective date: 20250110
2025-02-19	U07	Unitary effect registered	Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI Effective date: 20250117
2025-03-24	REG	Reference to a national code	Ref country code: GR Ref legal event code: EP Ref document number: 20250400287 Country of ref document: GR Effective date: 20250314